Skip to main content
. 2018 Feb 26;18:656–662. doi: 10.1016/j.nicl.2018.02.023

Table 1.

Characteristics of the patients.

Characteristics of the patients Number Mean (SD) %
All patients 82
3.0 T magnet 60 73.17%
1.5T magnet 22 26.83%
Age 38.11 (8.71)
Gender Male 40 48.78%
Female 42 51.22%
Handedness Right 67 81.71%
Left 8 9.76%
Ambidextrous 7 8.54%
Tumor side Right hemisphere 29 35.37%
Left hemisphere 53 64.63%
Location Frontal lobe 30 36.59%
Frontoinsular 7 8.54%
Temporal lobe 10 12.2%
Temporoinsular 6 7.32%
Insula 5 6.1%
Frontotemporoinsular 19 23.17%
Parietal 5 6.1%
Histopathologya Oligoastrocytoma, Grade II 66 80.49%
Oligoastrocytoma, Grade III 2 2.44%
Oligodendroglioma, Grade II 7 8.54%
Oligodendroglioma, Grade III 3 3.66%
Diffuse low grade glioma (no available histopathologic precision) 2 2.44%
Ganglioglioma, Grade I 2 2.44%
Mean volumes (mm3)
 MRI-1 Preoperative tumor 52.26 (40.23)
 MRI-2 Operative cavity 38.14 (23.67)
Residual tumor 13.82 (15.44)
 MRI-3 Operative cavity 33.11 (23.36)
Residual tumor 14.23 (15.92)
Transient immediate postoperative deficits Aphasia 33 40.24%
Sensorimotor deficit 11 13.41%
Cognitive deficit 1 1.22%
No deficit 40 48.78%
a

Histopathology is based on the 2007 WHO Classification of Tumors of the Central Nervous System (Louis et al., 2007). Patients were scanned successively before surgery (MRI-1), immediately after surgery, within 36 h following surgery (MRI-2), and three months after surgery (MRI-3).